Which are the causes of Hemolytic-uremic Syndrome?

TL;DR: Hemolytic-uremic syndrome (HUS) is primarily caused by infections, most notably Shiga toxin-producing E. coli, or by genetic mutations that lead to an overactive immune system. While the infectious form (typical HUS) is triggered by environmental toxins, the non-infectious form (atypical HUS) is often linked to inherited or acquired dysregulation of the body’s complement system.

What are the primary triggers of Hemolytic-uremic syndrome?

The causes of Hemolytic-uremic syndrome are generally categorized based on the underlying mechanism of injury to the small blood vessels (microangiopathy). The most common form, often called "typical" HUS, is triggered by an infection—usually Escherichia coli (STEC-HUS)—which releases Shiga toxins into the bloodstream. These toxins damage the lining of the blood vessels, leading to the formation of tiny clots. In contrast, "atypical" HUS (aHUS) is not triggered by an infection but by the body’s own immune system attacking its blood vessels, specifically due to a failure in the regulation of the complement system, which is a part of our innate immune defense.

Is Hemolytic-uremic syndrome hereditary?

Whether Hemolytic-uremic syndrome is hereditary depends on the type. While typical HUS is an environmental infection, atypical Hemolytic-uremic syndrome is frequently linked to genetic factors. In approximately 50-60% of aHUS cases, scientists have identified mutations in genes that regulate the complement system. These genes, such as CFH, CFI, MCP, and C3, provide instructions for proteins that normally prevent the immune system from damaging healthy cells. When these genes are mutated, the "brakes" on the immune system fail, causing it to attack the body's own tissues continuously.

What are the specific causes and risk factors for this condition?

Distinguishing between causes and risk factors is vital for managing Hemolytic-uremic syndrome. A "cause" is the direct mechanism of disease, while a "risk factor" increases the likelihood of an episode. For example, while a genetic mutation is a cause of aHUS, pregnancy or a minor viral infection can act as a risk factor that triggers the first clinical manifestation of the disease.

• Shiga toxin-producing bacteria: The leading cause of typical HUS, often contracted through contaminated food or water.


• Genetic mutations: Inherited variations in complement-regulatory proteins (e.g., CFH, C3, CFB) are the primary causes of atypical Hemolytic-uremic syndrome.


• Autoimmune factors: Some patients develop "autoantibodies" that block their own complement-regulatory proteins, effectively mimicking a genetic mutation.


• Environmental triggers: Medications (like certain chemotherapy agents), pregnancy, and systemic diseases (such as lupus or cancer) are known risk factors that can precipitate an aHUS episode.

How is research advancing our understanding of Hemolytic-uremic syndrome?

Medical research is currently focused on identifying the "missing" genetic triggers in the 30-40% of aHUS patients who do not show known mutations. Researchers are utilizing advanced genomic sequencing to map new variants and studying how environmental stressors interact with the complement system. Within the Hemolytic-uremic syndrome community at DiseaseMaps.org, patients are sharing their diagnostic journeys, which helps researchers correlate clinical outcomes with specific genetic profiles, ultimately moving the field toward more personalized, targeted therapies.

Next steps

• Consult a nephrologist or hematologist if you or a family member have experienced unexplained blood clots or kidney dysfunction.


• Seek genetic counseling if a family history of atypical Hemolytic-uremic syndrome is suspected.


• Join the 93 members of the Hemolytic-uremic syndrome community on DiseaseMaps.org to share experiences and stay updated on clinical trial opportunities.


• Maintain a detailed health diary to track potential triggers if you have been diagnosed with the atypical form of the condition.

Medical disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Hemolytic uremic syndrome.


• Orphanet: Atypical hemolytic uremic syndrome.


• OMIM (Online Mendelian Inheritance in Man): Atypical Hemolytic-Uremic Syndrome.


• National Kidney Foundation: Information on HUS and its impact on renal function.